
Torii Pharmaceutical Co Ltd
TSE:4551

Operating Margin
Torii Pharmaceutical Co Ltd
Operating Margin represents how efficiently a company is able to generate profit through its core operations.
Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.
Operating Margin Across Competitors
Country | Company | Market Cap |
Operating Margin |
||
---|---|---|---|---|---|
JP |
![]() |
Torii Pharmaceutical Co Ltd
TSE:4551
|
132B JPY |
11%
|
|
US |
![]() |
Eli Lilly and Co
NYSE:LLY
|
779.4B USD |
38%
|
|
UK |
![]() |
Dechra Pharmaceuticals PLC
LSE:DPH
|
440.4B GBP |
3%
|
|
US |
![]() |
Johnson & Johnson
NYSE:JNJ
|
394B USD |
26%
|
|
DK |
![]() |
Novo Nordisk A/S
CSE:NOVO B
|
2.1T DKK |
48%
|
|
CH |
![]() |
Roche Holding AG
SIX:ROG
|
236.5B CHF |
32%
|
|
UK |
![]() |
AstraZeneca PLC
LSE:AZN
|
177B GBP |
23%
|
|
US |
![]() |
Merck & Co Inc
NYSE:MRK
|
225.9B USD |
36%
|
|
CH |
![]() |
Novartis AG
SIX:NOVN
|
199.7B CHF |
32%
|
|
IE |
E
|
Endo International PLC
LSE:0Y5F
|
167.6B USD |
11%
|
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
142.8B USD |
25%
|
Torii Pharmaceutical Co Ltd
Glance View
Torii Pharmaceutical Co., Ltd. engages in the manufacturing and marketing of pharmaceutical products. The company is headquartered in Chuo-Ku, Tokyo-To and currently employs 560 full-time employees. The company went IPO on 2013-10-01. The Company’s main product categories include oral pruritus improving agents, proteolytic enzyme inhibitors, hyperkalemia improving agents, topical adrenocortical hormones, allergen immunotherapy for cedar pollinosis, allergen immunotherapy for mite allergy, active viable bacterial preparations, uterine contraction inhibitors in premature birth and others. The Company’s main products include Remitch, Riona tablets, Keixalate, Yulinome tablets, Antebate, Locoid, Zefnate, Sida Torengi pollen sublingual solution, Miticure mite sublingual tablet, Biosley, Magcent and others.

See Also
Operating Margin represents how efficiently a company is able to generate profit through its core operations.
Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.
Based on Torii Pharmaceutical Co Ltd's most recent financial statements, the company has Operating Margin of 11.3%.